About Kivi Labs Limited
Data last updated:
Kivi Labs Limited is a public limited company based in Por, Gujarat, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 04 October 2002 and has been in existence for over 24 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24231GJ2002PLC041375. Its GSTIN is 24AABCK9388D1ZE (Gujarat).
The company has an authorised share capital of ₹50 Lakh and a paid-up capital of ₹35.02 Lakh. It is led by directors including Pramodkumar Atmaram Agarwal (Managing Director) and Dharmisthaben Jayeshbhai Patel (Whole-Time Director).
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 147 – 148 GIDC Ramangamdi Por, Gujarat, India – 391243.
As per the financials filed for FY 2025, the company reported a revenue of ₹49.23 Cr, a growth of 6% compared to the previous year. For the same year it recorded a net profit of ₹1.52 Cr (net margin 3.1%) and EBITDA of ₹10.17 Cr (EBITDA margin 20.7%). Revenue has declined at a compounded annual rate (CAGR) of 3% over three years and 6% over five years.
The company has about 110 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹31.22 Cr and satisfied charges of ₹3.38 Cr on record. Court records list 21 cases involving the company, including 3 filed by the company and 18 filed against it; 3 cases are pending. The company has 3 deals on record (3 secondary share transfers); the latest was in September 2018. Its 8 peer companies in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 4 larger and 4 smaller; the largest is Sotac Healthcare Private Limited with revenue of ₹49.75 Cr. The company has 11 MSME Form 1 returns on record between 2019 and 2023, listing 141 overdue payments to 45 micro and small suppliers.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website kivilabs.com.
Company details
Contact details
Kivi Labs Limited's registered office is in Por, Gujarat. Its website is kivilabs.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address147 – 148 GIDC Ramangamdi Por, Gujarat, India – 391243
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Kivi Labs Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Kivi Labs is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Kivi Labs Limited, buy the company report.
Financials of Kivi Labs Limited
FY 2025 filings availableKivi Labs Limited reported revenue of ₹49.23 Cr (up 6% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 6% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 6%. EBITDA rose 27% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | ₹49.23 Cr | ||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹10.17 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.52 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 20.7% | ||||
| Net Profit Margin | 3.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Kivi Labs Limited, buy the company report.
Board of directors of Kivi Labs Limited
Kivi Labs has 4 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Dharmisthaben Jayeshbhai Patel | Whole-Time Director | 04 Oct 2002 | 24 Years 0 Months | Current |
| Pramodkumar Atmaram Agarwal | Managing Director | 04 Oct 2002 | 24 Years 0 Months | Current |
| Lata Pramod Kumar Agarwal | Whole-Time Director | 04 Oct 2002 | 24 Years 0 Months | Current |
| Jayesh Bhogilal Patel | Whole-Time Director | 04 Oct 2002 | 24 Years 0 Months | Current |
Peer comparison
Kivi Labs Limited is compared with the 8 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Sotac Healthcare Private Limited | ₹49.75 Cr (FY 2025) | 7.0% | Ahmedabad, Gujarat, India | |||
| Riocare India Private Limited | ₹49.75 Cr (FY 2025) | -1.0% | Navi Mumbai, Maharashtra, India | |||
| Medipol Pharmaceutical India Private Limited | ₹49.73 Cr (FY 2025) | 10.0% | Delhi, India | |||
| Akron Formulations India Private Limited | ₹49.28 Cr (FY 2025) | 83.0% | Hyderabad, Telangana, India | |||
| Kivi Labs Limitedthis company | ₹49.23 Cr (FY 2025) | ₹1.52 Cr | 3.1% | 6.0% | 110 | Por, Gujarat, India |
| Atoz Pharmaceuticals Private Limited | ₹49.04 Cr (FY 2025) | 20.0% | Ambattur Chenai, Tamil Nadu, India | |||
| Protech Bio Systems Private Limited | ₹48.99 Cr (FY 2025) | -17.0% | New Delhi, Delhi, India | |||
| Montage Laboratories Private Limited | ₹48.49 Cr (FY 2025) | 7.0% | Himatnagar, Gujarat, India | |||
| Sainor Pharma Private Limited | ₹48.47 Cr (FY 2016) | 0.0% | Hyderabad, Telangana, India |
To see the full peer comparison of Kivi Labs Limited, buy the company report.
Auditor
Kivi Labs Limited is audited by Rajesh Nagda & Co. for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Rajesh Nagda & Co. | FY 2024 | 151838W |
Shareholding
The shareholding of Kivi Labs Limited is on record for 5 financial years, the latest being FY 2025, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Kivi Labs Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 10 Dec 2025 | 101196894 | Hdfc Bank Limited | ₹1.26 Cr | Open | |
| 30 Sep 2025 | 101168406 | Hdfc Bank Limited | ₹20 Cr | Open | |
| 31 Mar 2025 | 101073461 | Hdfc Bank Limited | ₹30.5 Lakh | Open | |
| 29 Oct 2024 | 100995405 | Hdfc Bank Limited | ₹87 Lakh | Open | |
| 31 Jul 2023 | 100761864 | Others | ₹87 Lakh | Open |
To see the full charge records of Kivi Labs Limited, buy the company report.
Total charge records: 22 View all charges
Deals & funding
Kivi Labs Limited has 3 deals on record (3 secondary share transfers); the latest was in September 2018.
Deals on record (3 of 3)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Sep 2018 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: 2 individuals |
| Dec 2016 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Sep 2013 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: 2 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Kivi Labs Limited has 21 court cases on record: 3 filed by Kivi Labs, 18 filed against it. 3 cases are pending and 18 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 15 | 12 | 0 |
| District courts | 6 | 6 | 3 |
Cases on record (5 of 21)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Ahmedabad, Gujarat | Court case (CS CCC) | Filed against the company by Tripada Healthcare Private Limited | Pending |
| High Court of Delhi | Court case (CS(OS)) | Filed against the company by Sun Pharma Laboratories Ltd. | Disposed |
| District court, Ahmedabad, Gujarat | Court case (CS CCC) | Filed against the company by Intas Pharmaceuticals Ltd. | Disposed |
| District court, Thane, Maharashtra | Court case (R.C.C.) | Filed against the company by an individual | Pending |
| District court, Vadodara, Gujarat | Criminal complaint | Filed against the company by an individual | Pending |
To see the full case history of Kivi Labs Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Kivi Labs Limited has 11 MSME Form 1 returns on record between 2019 and 2023, listing 141 overdue payments to 45 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 45)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| an individual supplier | |||
| an individual supplier | |||
| Enngees Intra Chem | |||
| BRK Industries LLP | |||
| Imex Overseas |
To see the full MSME payment records of Kivi Labs Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Kivi Labs Limited has a workforce of 110 employees on its EPFO records as of Sep 22, 2025, across 1 active EPFO establishment.
GST
Kivi Labs has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AABCK9388D1ZE | Gujarat | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Kivi Labs Limited, buy the company report.
Recent activity
Kivi Labs Limited has 8 board changes on record since 2002: 4 appointments and 4 cessations. The latest: Jaykishan Jayeshbhai Patel ceased to be Director on 12 Jun 2013.
32 earlier events are in the company report.
Frequently asked questions
Kivi Labs is an active public limited company based in Por, Gujarat, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 04 October 2002 (24+ years old) and is registered under CIN U24231GJ2002PLC041375.
Kivi Labs has 4 current directors:
- Pramodkumar Atmaram Agarwal - Managing Director
- Dharmisthaben Jayeshbhai Patel - Whole-Time Director
- Lata Pramod Kumar Agarwal - Whole-Time Director
- Jayesh Bhogilal Patel - Whole-Time Director
The latest financial statements of Kivi Labs on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Kivi Labs is 24AABCK9388D1ZE, registered in Gujarat.
The CIN (Corporate Identification Number) of Kivi Labs is U24231GJ2002PLC041375. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Kivi Labs has 21 court cases on record: 3 filed by the company and 18 filed against it. 3 are pending. Most are in the high courts.
Kivi Labs was incorporated on 04 October 2002, making it 24+ years old. It is registered with the Registrar of Companies, Ahmedabad.
Kivi Labs has 3 deals on record (3 secondary share transfers); the latest was in September 2018.
The peers of Kivi Labs by revenue are Sotac Healthcare Private Limited, Riocare India Private Limited, Medipol Pharmaceutical India Private Limited, Akron Formulations India Private Limited, Atoz Pharmaceuticals Private Limited and 3 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Jaykishan Jayeshbhai Patel ceased to be Director on 12 Jun 2013. Megh Shyam Damodar Lal Gupta ceased to be Director on 12 Jun 2013. Rakesh Radhey Shayam Gupta ceased to be Director on 12 Jun 2013. Kivi Labs has 8 board changes on record in total.
Kivi Labs has 11 MSME Form 1 returns on record between 2019 and 2023, listing 141 overdue payments to 45 micro and small suppliers. The latest return was filed on 20 Oct 2023.
Kivi Labs can be reached through the website kivilabs.com. Its registered office is in Por, Gujarat, India.